Table 1.

Volumes, prescribed doses and type of RT for prostate and brain cancer groups.

Brain (n = 16)	Target	Meningioma	2
		Glioma	13
		Craniopharyngioma	1
	Prescribed dose (Gy)‐ (Gy/fraction x fractions)	60 – (2 x 30)	9
		54 – (1,8 x 30)	2
		52,2 – (1,8 x 29)	1
		40 – (2,66 x 15)	4
	Brain RT	Alone	6
		Post‐operative	10
Prostate (n = 31)	Target	Prostate alone	6
		Prostate and vesicles	3
		Prostate, vesicles and lymph nodes	19
		Prostate and bone metastases	1
		Prostate cavity and pelvis	2
	Prescribed dose (Gy)‐ (Gy/fraction x fractions)	78 – (2 x 39)	26
		74 – (2 x 37)	1
		66 – (2 x 33)	2
		60 – (3 x 20)	2
	Prostate RT	Alone	29
		Post‐operative	2